Attribution Statement: LactMed is a registered trademark of the U.S. Department of Health and Human Services.
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-.
CASRN: 149709-62-6
Drug Levels and Effects
Summary of Use during Lactation
Sacubitril is available in the United States only in combination with valsartan. Because no information is available on the use of sacubitril or valsartan during breastfeeding, an alternate drug may be preferred, especially while nursing a newborn or preterm infant.
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Alternate Drugs to Consider
Substance Identification
Substance Name
Sacubitril
CAS Registry Number
149709-62-6
Drug Class
- Breast Feeding
- Angiotensin-Converting Enzyme Inhibitors
- Antihypertensive Agents
- ACE Inhibitors
- ACEIs
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- User and Medical Advice Disclaimer
- Drugs and Lactation Database (LactMed) - Record Format
- LactMed - Database Creation and Peer Review Process
- Fact Sheet. Drugs and Lactation Database (LactMed)
- Drugs and Lactation Database (LactMed) - Glossary
- LactMed Selected References
- Drugs and Lactation Database (LactMed) - About Dietary Supplements
- Breastfeeding Links
- PubChem SubstanceRelated PubChem Substances
- Review Valsartan.[Drugs and Lactation Database (...]Review Valsartan.. Drugs and Lactation Database (LactMed®). 2006
- Novel O-[(11)C]-methylated derivatives of the neprilysin inhibitor sacubitril: Radiosynthesis, autoradiography and plasma stability evaluation.[Nucl Med Biol. 2021]Novel O-[(11)C]-methylated derivatives of the neprilysin inhibitor sacubitril: Radiosynthesis, autoradiography and plasma stability evaluation.Teyssier VR, Tournoux F, Simard JM, Gaudette F, Boudjemeline M, Petrenyov DR, DaSilva JN. Nucl Med Biol. 2021 Nov-Dec; 102-103:34-44. Epub 2021 Sep 20.
- Review Lovastatin.[Drugs and Lactation Database (...]Review Lovastatin.. Drugs and Lactation Database (LactMed®). 2006
- Review Azilsartan.[Drugs and Lactation Database (...]Review Azilsartan.. Drugs and Lactation Database (LactMed®). 2006
- Review Letermovir.[Drugs and Lactation Database (...]Review Letermovir.. Drugs and Lactation Database (LactMed®). 2006
- Sacubitril - Drugs and Lactation Database (LactMed®)Sacubitril - Drugs and Lactation Database (LactMed®)
Your browsing activity is empty.
Activity recording is turned off.
See more...